Ohio House Bill HB382

Ohio 2023-2024 Regular Session

• Introduced: 1/18/24
• Report Pass: 11/26/24
• Engrossed: 12/4/24

Caption

Regards prescription drug readers for visually impaired patients

Impact

The impact of HB 382 is primarily on healthcare plans and pharmacies across Ohio. By requiring health benefit plans to cover prescription readers, the bill seeks to create more equitable access to important medication information for visually impaired patients. This change not only aligns with state laws aimed at supporting people with disabilities but also underscores the importance of accessible healthcare solutions. The Medicaid program is also affected as it will now include coverage for these prescription readers, thereby promoting accessibility for low-income individuals who rely on Medicaid for health services.

Summary

House Bill 382 aims to enhance the accessibility of prescription medications for visually impaired patients in Ohio by mandating the availability of prescription drug readers. This legislation amends existing laws related to prescription drug services and establishes provisions that require licensed terminal distributors of dangerous drugs to inform customers about the availability of these readers when prescriptions are filled. The bill includes language that defines 'prescription readers' as devices that audibly convey required information about a drug label, including cautions and details on drug interactions, ensuring it is accessible for those who cannot read standard labels.

Contention

Potential areas of contention surrounding HB 382 may arise from the financial implications it imposes on pharmacies and health insurers regarding the additional coverage they must provide. There may also be logistical challenges in implementing the requirements of informing customers about the availability of prescription readers during transactions, especially for mail-order prescriptions. Stakeholders in the pharmacy and insurance industries might express concerns over the added administrative burdens and costs involved in compliance with this legislation, which could lead to debates during discussions about resource allocation within healthcare systems.